
Hypervision Surgical Ltd is a spin-out company formed from King's College London and was founded by a team of clinicians, medical imaging and artificial intelligence (AI) experts. Based on safe light alone, our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety.

Hypervision Surgical Ltd is a spin-out company formed from King's College London and was founded by a team of clinicians, medical imaging and artificial intelligence (AI) experts. Based on safe light alone, our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety.
Headquarters: London, United Kingdom
Product: HYPERSNAP® Surgical System — AI-powered hyperspectral imaging for real-time, dye-free tissue characterisation
Founding Origin: Spin-out from King's College London
Recent funding: £6.5M seed round (June 2023)
Intraoperative tissue characterisation and surgical guidance
Medical Equipment Manufacturing
£6.5M
Reported as oversubscribed seed round
Recorded as a non-equity assistance event
“Backed by a syndicate of European and American HealthTech investors including corporate venture arm of ZEISS”
About Hypervision Surgical Hypervision Surgical Ltd is a spin-out company formed from King’s College London and was founded by a team of clinicians, medical imaging and artificial intelligence (AI) experts. Based on safe light alone, our goal is to equip clinicians with advanced computer-assisted tissue analysis for improved surgical precision and patient safety.
We have developed a computational Hyperspectral Imaging (HSI) system for improved intraoperative surgical guidance. HSI is a safe optical imaging modality perfectly suited for the clinic. By splitting light into multiple wavelengths far beyond what the naked eye can see, HSI carries diagnostic information about tissue properties ideal for objective tissue characterisation. This will objectively enhance the surgeon’s ability to visualise and characterise tissue intraoperatively without injecting any toxic contrast agents. In addition, our system can monitor vital physiological tissue properties, thereby increasing surgical precision and patient safety while optimising resection.
Following successful in-patient clinical studies and development of a commercial medical device, we are excited to now place our patented technology into the hands of surgeons.
We are building our company at the intersection of surgery, machine learning and interventional image computing for optical systems to increase surgical precision and patient safety. We are backed by a highly
experienced syndicate of European and American HealthTech investors, including the corporate venture arm of ZEISS, a multinational technology leader. In addition, we are supported by the British Royal Academy of Engineering, Innovate UK, NIHR (National Institute for Health Research), the Creative Destruction Lab, and King’s Health Partners MedTech Innovations to improve surgical care.
Join us and help shape our growth toward Series A and beyond
About The Role We are seeking a curious, creative and motivated individual who is excited to join an innovation-driven, early-stage MedTech spin-out for a period of 3-6 months. We welcome a wide range of experiences where projects will be allocated based on background and interests.
Potential Topics Include
A Bit About You You would typically be enrolled in or graduated from a STEM-related degree programme including computer science, mathematics, physics, software engineering, robotics, or biomedical engineering.
Relevant expertise and interests: Machine learning, medical image computing, computer vision, image processing, video compression, data analytics, software development (Python, C/C++), scientific packages (PyTorch, OpenCV, Pandas, SciPy, Numpy), operating systems and cybersecurity (Linux), biophotonics, optical imaging systems, system integration, phantom development, oximetry.
What we offer
At Hypervision Surgical, we are committed to promoting equal opportunities in employment and creating a workplace culture in which diversity and inclusion is valued and everyone is treated with dignity and respect. As part of our zero-tolerance approach to discrimination in any form, all job applicants will receive equal treatment regardless of age, disability, gender reassignment, marital or civil partner status, pregnancy or maternity, race, colour, nationality, ethnic or national origin, religion or belief, sex or sexual orientation (Protected Characteristics).
A copy of our detailed Diversity, Equity and Inclusion Policy is available upon request. Please contact hr@hypervisionsurgical.com for more information.
| Company |
|---|